BioPharma

02 September, 2026 | Wednesday | News

Astellas Reaches US Government Agreement to Lower Medicaid Drug Prices, Strengthen Medicine Supply Chain

 Agreement supports commitment to patient access, affordability and innovation – Astellas Pharma Inc. announced that it has reached an agreement with the U.S. government that reflects our commitment...

Lab

26 August, 2026 | Wednesday | News

Thermo Fisher Launches First Orbitrap Isora Mass Spectrometers for Molecular-Level Isotope Analysis

New Orbitrap Isora workflow integrates mass spectrometry, Vanquish Duo UHPLC System and Isotope Discoverer Software to bring molecular-level isotope ratio analysis to more researchers worldwide Key highlights:...

BioTech

03 September, 2026 | Thursday | News

IDT and Ansa Expand Global Access to Complex DNA Synthesis Through Integrated Ordering

Streamlined workflow provides earlier visibility into synthesis feasibility, pricing, and fulfillment options Global adoption growing with more than 400 institutions across 33 countries ordering DNA construc...

Contract Services

01 September, 2026 | Tuesday | News

WuXi AppTec Raises 2026 Interim Dividend to RMB 1.51 Billion Amid Global CRDMO Expansion

WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), announces the distribution of its 2026 interim cas...

Consumer Health

01 September, 2026 | Tuesday | News

Ascletis Doses First Patient in Global Phase III Programme for Oral GLP-1 Obesity Drug ASC30

- Expected to enroll approximately 4,600 participants with obesity or overweight across two pivotal trials (AURORA-1 and AURORA-2) in the U.S., Europe, and Canada.  - Global Phase III clinical program to ...

Medtech

03 September, 2026 | Thursday | News

GE HealthCare’s Photonova Spectra Photon-Counting CT Secures CE Mark

Following U.S. FDA 510(k) clearance and Japanese regulatory approval, Photonova Spectra has also achieved CE Mark, supporting expanded research and clinical adoption across Europe and other global markets Po...

Cell & Gene

03 September, 2026 | Thursday | News

Genprex Selects Andelyn Biosciences to Scale Up AAV Gene Therapy for Diabetes

Andelyn Biosciences, a leading contract development and manufacturing organization, announced that Genprex, Inc. has selected Andelyn to support scale-up manufacturing for its diabetes gene therapy program. Ge...


White Paper

03 September, 2026 | Thursday | Analysis

Food, Drug, or Neither

Premium Article

Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close